{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:55:05Z","timestamp":1787846105578,"version":"build-2784847793"},"reference-count":116,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jhep.2023.02.012","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T14:42:24Z","timestamp":1684334544000},"page":"1157-1168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Issues in multi-organ transplantation of the liver with kidney or heart in polycystic liver-kidney disease or congenital heart disease: Current practices and immunological aspects"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0641-2930","authenticated-orcid":false,"given":"Timucin","family":"Taner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4596-5952","authenticated-orcid":false,"given":"Moira B.","family":"Hilscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6844-2348","authenticated-orcid":false,"given":"Christopher R.","family":"Broda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8027-3073","authenticated-orcid":false,"given":"Joost P.H.","family":"Drenth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2023.02.012_bib1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCULATIONAHA.113.008396","article-title":"Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010","volume":"130","author":"Marelli","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jhep.2023.02.012_bib2","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1111\/ajt.13749","article-title":"Functional immune anatomy of the liver-as an allograft","volume":"16","author":"Demetris","year":"2016","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jhep.2023.02.012_bib3","first-page":"391","article-title":"Not all cellular rejections are the same: differences in early and late hepatic allograft rejection","volume":"17","author":"Jadlowiec","year":"2017","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jhep.2023.02.012_bib4","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41575-020-0334-4","article-title":"Understanding, predicting and achieving liver transplant tolerance: from bench to bedside","volume":"17","author":"Thomson","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.02.012_bib5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/lt.25718","article-title":"Phenotypic, transcriptional, and functional analysis of liver mesenchymal stromal cells and their immunomodulatory properties","volume":"26","author":"Taner","year":"2020","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2023.02.012_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12026-011-8223-0","article-title":"Hepatic antigen-presenting cells and regulation of liver transplant outcome","volume":"50","author":"Thomson","year":"2011","journal-title":"Immunol Res"},{"key":"10.1016\/j.jhep.2023.02.012_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2022.952262","article-title":"Liver mesenchymal stromal cells are superior inhibitors of NK cell gunctions through differences in their secretome compared to other mesenchymal stem cells","volume":"13","author":"Yigitbilek FO","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2023.02.012_bib8","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.3748\/wjg.v25.i25.3123","article-title":"Revisiting the liver's role in transplant alloimmunity","volume":"25","author":"Abrol","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2023.02.012_bib9","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1002\/lt.24840","article-title":"Liver transplantation: rejection and tolerance","volume":"23","author":"Taner","year":"2017","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2023.02.012_bib10","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/223472a0","article-title":"Induction of immunological tolerance by porcine liver allografts","volume":"223","author":"Calne","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2023.02.012_bib11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00007890-198005000-00021","article-title":"Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens","volume":"29","author":"Kamada","year":"1980","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2023.02.012_bib12","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/292840a0","article-title":"Reversal of transplantation immunity by liver grafting","volume":"292","author":"Kamada","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2023.02.012_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00007890-198409000-00004","article-title":"Antigen-specific immunosuppression induced by liver transplantation in the rat","volume":"38","author":"Kamada","year":"1984","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2023.02.012_bib14","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/01.TP.0000071204.03720.BB","article-title":"Analysis of the United Network for Organ Sharing database comparing renal allografts and patient survival in combined liver-kidney transplantation with the contralateral allografts in kidney alone or kidney-pancreas transplantation","volume":"76","author":"Fong","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2023.02.012_bib15","first-page":"88","article-title":"Combined liver-kidney transplantation: analysis of patients with preformed lymphocytotoxic antibodies","volume":"20","author":"Fung","year":"1988","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2023.02.012_bib16","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/00007890-199503270-00025","article-title":"Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival","volume":"59","author":"Rasmussen","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2023.02.012_bib17","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1097\/TP.0b013e3182184181","article-title":"Combined liver-kidney transplants: allosensitization and recipient outcomes","volume":"91","author":"Askar","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2023.02.012_bib18","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.kint.2015.10.016","article-title":"Decreased chronic cellular and antibody-mediated injury in the kidney following simultaneous liver-kidney transplantation","volume":"89","author":"Taner","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2023.02.012_bib19","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/j.1600-6143.2012.03995.x","article-title":"Prevalence, course and impact of HLA donor-specific antibodies in liver transplantation in the first year","volume":"12","author":"Taner","year":"2012","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jhep.2023.02.012_bib20","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1111\/ajt.13870","article-title":"Liver allograft provides immunoprotection for the cardiac allograft in combined heart-liver transplantation","volume":"16","author":"Wong","year":"2016","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jhep.2023.02.012_bib21","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.kint.2018.01.022","article-title":"Donor-specific hypo-responsiveness occurs in simultaneous liver-kidney transplant recipients after the first year","volume":"93","author":"Taner","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2023.02.012_bib22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/liv.12917","article-title":"Peripheral phenotype and gene expression profiles of combined liver-kidney transplant patients","volume":"36","author":"Dumontet","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2023.02.012_bib23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nrneph.2016.9","article-title":"Memory T cells in organ transplantation: progress and challenges","volume":"12","author":"Espinosa","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jhep.2023.02.012_bib24","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.kint.2016.12.016","article-title":"Unique molecular changes in kidney allografts after simultaneous liver-kidney compared with solitary kidney transplantation","volume":"91","author":"Taner","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.jhep.2023.02.012_bib25","article-title":"Intra-operative kinetics of anti-HLA antibody in simultaneous liver-kidney transplantation","volume":"26","author":"Kueht","year":"2021","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.jhep.2023.02.012_bib26","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/ajt.16913","article-title":"Alloantibodies after simultaneous liver-kidney transplant: a story of primary nonfunction, retransplantation, and antibody-mediated rejection","volume":"22","author":"Ramon","year":"2022","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jhep.2023.02.012_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jamcollsurg.2019.04.019","article-title":"A\u00a0tale of two kidneys: differences in graft survival for kidneys allocated to simultaneous liver kidney transplant compared with contralateral kidney from the same donor","volume":"229","author":"Cannon","year":"2019","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.jhep.2023.02.012_bib28","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1097\/TP.0000000000003694","article-title":"Crossmatch, donor-specific antibody testing, and immunosuppression in simultaneous liver and kidney transplantation: a review","volume":"105","author":"Das","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2023.02.012_bib29","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1097\/TXD.0000000000000633","article-title":"Successful simultaneous liver-kidney transplantation in the presence of multiple high-titered class I and II antidonor HLA antibodies","volume":"2","author":"Paterno","year":"2016","journal-title":"Transpl Direct"},{"key":"10.1016\/j.jhep.2023.02.012_bib30","doi-asserted-by":"crossref","first-page":"e569","DOI":"10.1097\/TXD.0000000000001004","article-title":"Kidney rejection following simultaneous liver-kidney transplantation","volume":"6","author":"Shah","year":"2020","journal-title":"Transpl Direct"},{"key":"10.1016\/j.jhep.2023.02.012_bib31","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.jacc.2021.01.013","article-title":"Heart-after-liver transplantation attenuates rejection of cardiac allografts in sensitized patients","volume":"77","author":"Daly","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jhep.2023.02.012_bib32","article-title":"Adult combined heart-liver transplantation: the United States experience","volume":"35","author":"Alexopoulos","year":"2021","journal-title":"Transpl Int : official J Eur Soc Organ Transplant"},{"key":"10.1016\/j.jhep.2023.02.012_bib33","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jhep.2017.11.024","article-title":"Clinical management of polycystic liver disease","volume":"68","author":"van Aerts","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.02.012_bib34","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1073\/pnas.1309438111","article-title":"Whole-exome sequencing reveals LRP5 mutations and canonical Wnt signaling associated with hepatic cystogenesis","volume":"111","author":"Cnossen","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2023.02.012_bib35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev-pathol-042320-121247","article-title":"Polycystic liver disease: advances in understanding and treatment","volume":"17","author":"Masyuk","year":"2022","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jhep.2023.02.012_bib36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/liv.13965","article-title":"Severity in polycystic liver disease is associated with aetiology and female gender: results of the International PLD Registry","volume":"39","author":"van Aerts","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2023.02.012_bib37","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/ndt\/gfw008","article-title":"Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease","volume":"31","author":"Chebib","year":"2016","journal-title":"Nephrology, Dialysis, Transplantation: Official Publication Eur Dial Transpl Assoc - Eur Ren Assoc"},{"key":"10.1016\/j.jhep.2023.02.012_bib38","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2036.2011.04923.x","article-title":"The long-term outcome of patients with polycystic liver disease treated with lanreotide","volume":"35","author":"Chrispijn","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2023.02.012_bib39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2019.04.018","article-title":"Lanreotide reduces liver growth in patients with autosomal dominant polycystic liver and kidney disease","volume":"157","author":"van Aerts","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2023.02.012_bib40","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1681\/ASN.2009121291","article-title":"Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease","volume":"21","author":"Hogan","year":"2010","journal-title":"J\u00a0Am Soc Nephrol : JASN"},{"key":"10.1016\/j.jhep.2023.02.012_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257606","article-title":"Somatostatin analog therapy effectiveness on the progression of polycystic kidney and liver disease: a systematic review and meta-analysis of randomized clinical trials","volume":"16","author":"Suwabe","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2023.02.012_bib42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrgastro.2012.254","article-title":"Diagnosis and management of polycystic liver disease","volume":"10","author":"Gevers","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.02.012_bib43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12882-017-0578-6","article-title":"The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regression","volume":"18","author":"Neijenhuis","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.jhep.2023.02.012_bib44","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/SLA.0b013e3181ad83dc","article-title":"Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation","volume":"250","author":"Schnelldorfer","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2023.02.012_bib45","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/hep.29582","article-title":"Polycystic liver disease: hepatic venous outflow obstruction lesions of the noncystic parenchyma have major consequences","volume":"68","author":"Barbier","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.02.012_bib46","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.cgh.2015.05.039","article-title":"Lanreotide reduces liver volume, but might not improve muscle wasting or weight loss, in patients with symptomatic polycystic liver disease","volume":"13","author":"Temmerman","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2023.02.012_bib47","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1007\/s10620-021-07125-9","article-title":"Gender differences in liver transplantation outcomes in polycystic liver disease","volume":"67","author":"Chauhan","year":"2022","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2023.02.012_bib48","first-page":"4183","article-title":"Long-term results of liver transplantation for polycystic liver disease: single-center experience in China","volume":"17","author":"Ding","year":"2019","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jhep.2023.02.012_bib49","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.jhep.2022.06.002","article-title":"EASL Clinical Practice Guidelines on the management of cystic liver diseases","volume":"77","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.02.012_bib50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/hep.28545","article-title":"Development and validation of a disease-specific questionnaire to assess patient-reported symptoms in polycystic liver disease","volume":"64","author":"Neijenhuis","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.02.012_bib51","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1097\/TP.0000000000001711","article-title":"Waitlisted candidates with polycystic liver disease are more likely to be transplanted than those with chronic liver failure","volume":"101","author":"Doshi","year":"2017","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.jhep.2023.02.012_bib52","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1002\/lt.26516","article-title":"Renal dysfunction after liver transplantation for polycystic liver disease","volume":"28","author":"Nayagam","year":"2022","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2023.02.012_bib53","first-page":"11","article-title":"Predictors of kidney delayed graft function and its prognostic impact following combined liver-kidney transplantation: a recent single-center experience","author":"Vincenzi","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jhep.2023.02.012_bib54","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14651","article-title":"Perioperative fluid management and outcomes in adult deceased donor liver transplantation - a systematic review of the literature and expert panel recommendations","volume":"36","author":"Morkane","year":"2022","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jhep.2023.02.012_bib55","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1097\/TP.0000000000003581","article-title":"Fluid management during kidney transplantation: a consensus statement of the committee on transplant anesthesia of the American society of anesthesiologists","volume":"105","author":"Wagener","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2023.02.012_bib56","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/tri.13358","article-title":"2018 annual report of the European liver transplant Registry (ELTR) - 50-year evolution of liver transplantation","volume":"31","author":"Adam","year":"2018","journal-title":"Transpl Int : official J Eur Soc Organ Transplant"},{"key":"10.1016\/j.jhep.2023.02.012_bib57","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/liv.13041","article-title":"Combined liver-kidney transplantation for polycystic liver and kidney disease: analysis from the United Network for Organ Sharing dataset","volume":"36","author":"Coquillard","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2023.02.012_bib58","article-title":"Liver transplant for unusually large polycystic liver disease: challenges and pitfalls","volume":"2018","author":"Serrano Rodriguez","year":"2018","journal-title":"Case Rep Transpl"},{"key":"10.1016\/j.jhep.2023.02.012_bib59","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jamcollsurg.2014.03.058","article-title":"A\u00a020-year experience with liver transplantation for polycystic liver disease: does previous palliative surgical intervention affect outcomes?","volume":"219","author":"Baber","year":"2014","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.jhep.2023.02.012_bib60","article-title":"Native nephrectomy before and after renal transplantation in patients with autosomal dominant polycystic kidney disease (ADPKD)","volume":"8","author":"Maxeiner","year":"2019","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jhep.2023.02.012_bib61","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1111\/ajt.16310","article-title":"Simultaneous bilateral laparoscopic nephrectomy with kidney transplantation in patients with ESRD due to ADPKD: a single-center experience","volume":"21","author":"Abrol","year":"2021","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jhep.2023.02.012_bib62","article-title":"Survival in children with congenital heart disease: have we reached a peak at 97%?","volume":"9","author":"Mandalenakis","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jhep.2023.02.012_bib63","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijcard.2016.02.133","article-title":"Cause of death in adults with congenital heart disease - an analysis of the German National Register for Congenital Heart Defects","volume":"211","author":"Engelings","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jhep.2023.02.012_bib64","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/CIRCULATIONAHA.115.017202","article-title":"Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre","volume":"132","author":"Diller","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jhep.2023.02.012_bib65","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1136\/heartjnl-2017-312777","article-title":"Causes of death in a contemporary adult congenital heart disease cohort","volume":"104","author":"Yu","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.jhep.2023.02.012_bib66","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s10741-020-09932-0","article-title":"Diagnosis and management of the adult patient with a failing Fontan circulation","volume":"25","author":"Broda","year":"2020","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jhep.2023.02.012_bib67","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/heartjnl-2015-307467","article-title":"The Fontan circulation after 45 years: update in physiology","volume":"102","author":"Gewillig","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.jhep.2023.02.012_bib68","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/hep.32406","article-title":"Fontan-associated liver disease","volume":"75","author":"Hilscher","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.02.012_bib69","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jtcvs.2012.09.005","article-title":"Identifying predictors of hepatic disease in patients after the Fontan operation: a postmortem analysis","volume":"146","author":"Johnson","year":"2013","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jhep.2023.02.012_bib70","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1161\/CIRCULATIONAHA.117.032717","article-title":"Hepatocellular carcinoma after fontan operation: multicenter case series","volume":"138","author":"Egbe","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jhep.2023.02.012_bib71","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1253\/circj.CJ-17-1053","article-title":"Liver cirrhosis and\/or hepatocellular carcinoma occurring late after the fontan procedure - a nationwide survey in Japan","volume":"82","author":"Kuwabara","year":"2018","journal-title":"Circ J"},{"key":"10.1016\/j.jhep.2023.02.012_bib72","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/eurheartj\/ehy620","article-title":"The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohort","volume":"40","author":"Munsterman","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jhep.2023.02.012_bib73","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1136\/hrt.2010.201772","article-title":"Late hepatic complications after Fontan operation; non-invasive markers of hepatic fibrosis and risk factors","volume":"96","author":"Baek","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.jhep.2023.02.012_bib74","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/hrt.2006.094516","article-title":"Hepatic changes in the failing Fontan circulation","volume":"93","author":"Kiesewetter","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.jhep.2023.02.012_bib75","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.amjcard.2015.11.014","article-title":"Liver disease in patients after the fontan operation","volume":"117","author":"Pundi","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jhep.2023.02.012_bib76","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s00246-020-02291-5","article-title":"Severity of fontan-associated liver disease correlates with fontan hemodynamics","volume":"41","author":"Schleiger","year":"2020","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jhep.2023.02.012_bib77","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.amjcard.2014.10.032","article-title":"Impact of liver disease after the fontan operation","volume":"115","author":"Lindsay","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jhep.2023.02.012_bib78","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/eurjhf\/hfn031","article-title":"Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: assessment of Reduction in Mortality and Morbidity (CHARM) program","volume":"11","author":"Allen","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jhep.2023.02.012_bib79","article-title":"From congestive hepatopathy to hepatocellular carcinoma, how can we improve patient management?","volume":"3","author":"Sessa","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2023.02.012_bib80","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.healun.2015.01.993","article-title":"Portal and centrilobular hepatic fibrosis in Fontan circulation and clinical outcomes","volume":"34","author":"Wu","year":"2015","journal-title":"J\u00a0Heart Lung Transpl"},{"key":"10.1016\/j.jhep.2023.02.012_bib81","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1148\/rg.2016160042","article-title":"Elastography in chronic liver disease: modalities, techniques, limitations, and future directions","volume":"36","author":"Srinivasa Babu","year":"2016","journal-title":"Radiographics"},{"key":"10.1016\/j.jhep.2023.02.012_bib82","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jtcvs.2007.09.039","article-title":"Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers","volume":"135","author":"Friedrich-Rust","year":"2008","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jhep.2023.02.012_bib83","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.mayocp.2015.04.020","article-title":"Magnetic resonance elastography: a novel technique for the detection of hepatic fibrosis and hepatocellular carcinoma after the fontan operation","volume":"90","author":"Poterucha","year":"2015","journal-title":"Mayo Clinic Proc"},{"key":"10.1016\/j.jhep.2023.02.012_bib84","first-page":"202","article-title":"Non-invasive assessment of liver fibrosis by magnetic resonance elastography in patients with congenital heart disease undergoing the Fontan procedure and intracardiac repair","volume":"68","author":"Sugimoto","year":"2016","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.jhep.2023.02.012_bib85","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.amjcard.2019.07.052","article-title":"Relation of magnetic resonance elastography to fontan failure and portal hypertension","volume":"124","author":"Alsaied","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jhep.2023.02.012_bib86","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2214\/AJR.18.19762","article-title":"Multimodality screening of hepatic nodules in patients with congenital heart disease after fontan procedure: role of ultrasound, ARFI elastography, CT, and MRI","volume":"211","author":"Horvat","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jhep.2023.02.012_bib87","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijcard.2010.05.047","article-title":"Arterialised hepatic nodules in the Fontan circulation: hepatico-cardiac interactions","volume":"151","author":"Bryant","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jhep.2023.02.012_bib88","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jpeds.2012.12.071","article-title":"Magnetic resonance imaging identifies unsuspected liver abnormalities in patients after the Fontan procedure","volume":"163","author":"Bulut","year":"2013","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jhep.2023.02.012_bib89","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s00247-012-2531-y","article-title":"Hepatic pathology after Fontan palliation: spectrum of imaging findings","volume":"43","author":"Wallihan","year":"2013","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.jhep.2023.02.012_bib90","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1007\/s00261-017-1181-9","article-title":"Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma","volume":"42","author":"Wells","year":"2017","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.jhep.2023.02.012_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071805","article-title":"Risk of liver cirrhosis and hepatocellular carcinoma after fontan operation: a need for surveillance","volume":"12","author":"Yoon","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jhep.2023.02.012_bib92","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.02.012_bib93","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jhep.2019.10.027","article-title":"Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: the VALDIG Fonliver prospective cohort","volume":"72","author":"T\u00e9llez","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.02.012_bib94","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1007\/s00261-021-02994-0","article-title":"Spectrum of Fontan-associated liver disease assessed by MRI and US in young adolescents","volume":"46","author":"Thrane","year":"2021","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.jhep.2023.02.012_bib95","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.cjco.2020.04.011","article-title":"Hepatic venous pressure gradient in fontan physiology has limited diagnostic and prognostic significance","volume":"2","author":"Egbe","year":"2020","journal-title":"CJC Open"},{"key":"10.1016\/j.jhep.2023.02.012_bib96","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1016\/j.ijcard.2013.06.008","article-title":"Features of portal hypertension are associated with major adverse events in Fontan patients: the VAST study","volume":"168","author":"Elder","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jhep.2023.02.012_bib97","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10741-019-09895-x","article-title":"General principles of heart failure management in adult congenital heart disease","volume":"25","author":"Tompkins","year":"2020","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jhep.2023.02.012_bib98","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijcard.2017.10.086","article-title":"Phenotype, management and predictors of outcome in a large cohort of adult congenital heart disease patients with heart failure","volume":"252","author":"Van De Bruaene","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jhep.2023.02.012_bib99","first-page":"1723","article-title":"Heart failure in adult congenital heart disease: from advanced therapies to end-of-life care","volume":"35","author":"Crossland","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jhep.2023.02.012_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2015.10.023","article-title":"The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update","volume":"35","author":"Mehra","year":"2016","journal-title":"J\u00a0Heart Lung Transpl"},{"key":"10.1016\/j.jhep.2023.02.012_bib101","first-page":"1072","article-title":"Heart transplant indications, considerations, and outcomes in fontan patients: age-related nuances, transplant listing, and disease-specific indications","volume":"38","author":"Dipchand","year":"2022","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jhep.2023.02.012_bib102","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1136\/heartjnl-2019-314711","article-title":"Outcome following heart transplant assessment in adults with congenital heart disease","volume":"105","author":"Crossland","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.jhep.2023.02.012_bib103","unstructured":"ACTION. [cited; Available from: actionlearningnetwork.org."},{"key":"10.1016\/j.jhep.2023.02.012_bib104","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.athoracsur.2016.08.110","article-title":"Fontan patient survival after pediatric heart transplantation has\u00a0improved\u00a0in the current era","volume":"103","author":"Simpson","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jhep.2023.02.012_bib105","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.amjcard.2017.01.001","article-title":"Meta-analysis of the effectiveness of heart transplantation in patients with a failing fontan","volume":"119","author":"Tabarsi","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jhep.2023.02.012_bib106","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1136\/heartjnl-2016-310933","article-title":"Successful cardiac transplantation outcomes in patients with adult congenital heart disease","volume":"103","author":"Menachem","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.jhep.2023.02.012_bib107","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40472-021-00315-4","article-title":"Orthotopic heart and combined heart liver transplantation: the ultimate treatment option for failing fontan physiology","volume":"8","author":"Reardon","year":"2021","journal-title":"Curr Transpl Rep"},{"key":"10.1016\/j.jhep.2023.02.012_bib108","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/CIRCULATIONAHA.120.045597","article-title":"Fontan-associated liver disease: screening, management, and transplant considerations","volume":"142","author":"Emamaullee","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jhep.2023.02.012_bib109","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1097\/TP.0000000000001978","article-title":"Contemporary outcomes of combined heart-liver transplant in patients with congenital heart disease","volume":"102","author":"Bryant","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2023.02.012_bib110","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/hep.31426","article-title":"Simultaneous heart-liver transplantation for congenital heart disease in the United States: rapidly increasing with acceptable outcomes","volume":"73","author":"Cotter","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.02.012_bib111","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.12892","article-title":"Single-center outcomes of combined heart and liver transplantation in the failing Fontan","volume":"31","author":"D'Souza","year":"2017","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jhep.2023.02.012_bib112","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13540","article-title":"Short-term outcomes of en bloc combined heart and\u00a0liver\u00a0transplantation in the failing Fontan","volume":"33","author":"Vaikunth","year":"2019","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jhep.2023.02.012_bib113","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.healun.2021.10.020","article-title":"Fate of the liver in the survivors of adult heart transplant for a failing Fontan circulation","volume":"41","author":"Broda","year":"2022","journal-title":"J\u00a0Heart Lung Transpl"},{"key":"10.1016\/j.jhep.2023.02.012_bib114","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.healun.2013.10.033","article-title":"Liver cirrhosis in Fontan patients does not affect 1-year post-heart transplant mortality or markers of liver function","volume":"33","author":"Simpson","year":"2014","journal-title":"J\u00a0Heart Lung Transpl"},{"key":"10.1016\/j.jhep.2023.02.012_bib115","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/ejcts\/ezu280","article-title":"Favourable mid-term outcome after heart transplantation for late Fontan failure","volume":"47","author":"Michielon","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jhep.2023.02.012_bib116","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.003754","article-title":"Regression of advanced liver fibrosis after heart transplantation in a patient with prior fontan surgery for complex congenital heart disease","volume":"11","author":"Bouchardy","year":"2018","journal-title":"Circ Heart Fail"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823001009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823001009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:51:21Z","timestamp":1759175481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827823001009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":116,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0168827823001009"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2023.02.012","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Issues in multi-organ transplantation of the liver with kidney or heart in polycystic liver-kidney disease or congenital heart disease: Current practices and immunological aspects","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2023.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}